Vulvovaginal Candidiasis Revenue Growth, New Launches, Regional Share Analysis & Forecast Till 2030
The market for Vulvovaginal Candidiasis (VVC) was valued at USD 971.51 million in 2021 and is anticipated to grow at a 4.2% CAGR in terms of revenue during the projected period. The rise in vulvovaginal candidiasis infections in women around the world, rising regulatory approvals for vulvovaginal candidiasis treatments, and an increase in clinical research studies into vulvovaginal candidiasis treatments are key factors propelling this market's revenue growth. Recent years have seen rapid developments in the information and communication technology sector, with the industry projected to grow substantially in revenue over the next five years. ICT industry technology advancements, increasing adoption of advanced and latest devices, an increasing number of consumers using these devices, and high internet penetration worldwide are expected to drive global market revenue growth throughout the forecast period. Get a sample of the report from @ https://www.emergenresearch.com/request-s...